Log In Get Started
Insider Trading November 10, 2026 06:34 PM

IBEX Sales Chief Casteel Offloads $592,206 in Shares Near 52-Week High

The chief sales and marketing officer's sale comes as the stock trades just below its peak, following a 61% six-month rally.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
IBEX

Julie K Casteel, Chief Sales/Marketing Officer at IBEX Ltd, sold 11,677 common shares on November 10, 2026, for a total of $592,206. The shares were sold at prices between $50.32 and $51.22, with a weighted average of $50.7156. The sale occurred as IBEX stock trades at $52.23, near its 52-week high of $52.29, after a 61% gain over six months. Following the transaction, Casteel directly holds 100,594 shares. An analysis suggests the stock appears overvalued relative to its Fair Value. Separately, IBEX reported fiscal first-quarter results that beat analyst expectations, with adjusted earnings of $1.10 per share on revenue of $175.2 million, and raised its full-year outlook.

IBEX Sales Chief Casteel Offloads $592,206 in Shares Near 52-Week High
IBEX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Casteel sold 11,677 shares for $592,206 at a weighted average price of $50.7156, near the stock's 52-week high.
  • The sale comes after a 61% six-month rally that has pushed IBEX shares to $52.23, just below the 52-week high of $52.29.
  • IBEX reported better-than-expected fiscal first-quarter results, with adjusted EPS of $1.10 and record revenue of $175.2 million, and raised its full-year outlook.

IBEX Ltd's Chief Sales/Marketing Officer, Julie K Casteel, sold 11,677 common shares of the company on November 10, 2026, according to a recent disclosure. The transaction totaled $592,206.

The shares changed hands at prices ranging from $50.32 to $51.22, yielding a weighted average sale price of $50.7156 per share. The sale attracted attention because IBEX stock currently trades at $52.23, virtually at its 52-week high of $52.29, following a remarkable 61% surge over the past six months.

After the transaction, Ms. Casteel directly holds 100,594 common shares of IBEX Ltd. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value. Investors seeking deeper insights can access 12 additional InvestingPro Tips, along with comprehensive financial health scores and detailed Pro Research Reports covering IBEX and 1,400+ other US equities.

In other recent news, IBEX has reported fiscal first-quarter results that exceeded analyst expectations. The company announced adjusted earnings of $1.10 per share, surpassing the projected $0.93 per share. Revenue for the quarter reached a record $175.2 million, outperforming the anticipated $168.93 million. Additionally, IBEX has raised its full-year outlook, reflecting confidence in its ongoing performance. The company's revenue showed a notable increase of 16% compared to the same period last year. These developments highlight a strong start to the fiscal year for IBEX.

Risks

  • The stock appears overvalued relative to its Fair Value, according to InvestingPro analysis, which could lead to a price correction.
  • Insider selling near a 52-week high may be interpreted by some investors as a lack of confidence in the stock's near-term prospects.
  • The company's raised outlook and recent strong results may set high expectations for future performance, leaving little room for disappointment.

More from Insider Trading

Arthur J. Gallagher CHRO Offloads $4.24 Million in Shares Following Option Exercise Nov 10, 2026 indie Semiconductor CFO Offloads $68,000 in Stock Under Pre-Set Trading Plan Nov 10, 2026 Silvaco Director Tewksbury Offloads $7,142 in Shares as Stock Rebounds Nov 10, 2026 Silvaco Director Bo-Linn Cheemin Executes Planned Stock Sale, Receives Equity Award Nov 10, 2026 Tapestry Executive Sells $1.5 Million in Stock After Option Exercise Nov 10, 2026